Location History:
- Haryana, IN (2008 - 2009)
- Gurgaon, IN (2010)
Company Filing History:
Years Active: 2008-2010
Title: Innovations by Sankaranarayanan Dharmarajan
Introduction
Sankaranarayanan Dharmarajan is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various inflammatory and autoimmune diseases. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves monosaccharide derivatives that serve as anti-inflammatory agents. This invention focuses on compounds that can inhibit and prevent inflammation and associated pathologies, including diseases such as bronchial asthma, rheumatoid arthritis, and cancer. The pharmacological compositions derived from these compounds offer methods for treating a range of inflammatory and autoimmune disorders.
Another significant patent by Dharmarajan pertains to azabicyclo derivatives as muscarinic receptor antagonists. This invention is aimed at treating various diseases of the respiratory, urinary, and gastrointestinal systems that are mediated through muscarinic receptors. The pharmaceutical compositions developed from these compounds provide innovative methods for addressing these health issues.
Career Highlights
Sankaranarayanan Dharmarajan is currently associated with Ranbaxy Laboratories, Inc., where he continues to contribute to pharmaceutical research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
He has collaborated with notable colleagues such as Mohammad Salman and Anita Mehta, further enhancing the collaborative spirit of innovation within his field.
Conclusion
Sankaranarayanan Dharmarajan's contributions to the pharmaceutical industry through his patents reflect his dedication to addressing critical health challenges. His innovative work in developing anti-inflammatory agents and muscarinic receptor antagonists showcases the potential of scientific research to improve lives.